XML 121 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jun. 30, 2023   12,622      
Beginning balance at Jun. 30, 2023 $ 34,649 $ 1 $ 134,314 $ (98,305) $ (1,361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 978   978    
Common stock issued under equity award plans (in shares)   281      
Shares canceled or surrendered as payment of tax withholding and other (in shares)   (90)      
Shares canceled or surrendered as payment of tax withholding and other (465)   (465)    
Repurchase of company stock (in shares)   145      
Repurchase of company stock (795)     (795)  
Common stock issued under employee stock purchase plan (in shares)   39      
Common stock issued under employee stock purchase plan 126   126    
Cash dividends (5,534)     (5,534)  
Currency translation adjustment (294)       (294)
Net income 629     629  
Ending balance (in shares) at Sep. 30, 2023   12,707      
Ending balance at Sep. 30, 2023 29,294 $ 1 134,953 (104,005) (1,655)
Beginning balance (in shares) at Jun. 30, 2023   12,622      
Beginning balance at Jun. 30, 2023 $ 34,649 $ 1 134,314 (98,305) (1,361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued under employee stock purchase plan (in shares) 64        
Net income $ 1,632        
Ending balance (in shares) at Mar. 31, 2024   12,688      
Ending balance at Mar. 31, 2024 26,769 $ 1 136,198 (107,709) (1,721)
Beginning balance (in shares) at Sep. 30, 2023   12,707      
Beginning balance at Sep. 30, 2023 29,294 $ 1 134,953 (104,005) (1,655)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 750   750    
Common stock issued under equity award plans (in shares)   495      
Shares canceled or surrendered as payment of tax withholding and other (in shares)   (34)      
Shares canceled or surrendered as payment of tax withholding and other (213)   (213)    
Repurchase of company stock (in shares)   288      
Repurchase of company stock (1,876)     (1,876)  
Cash dividends (455)     (455)  
Currency translation adjustment 463       463
Net income (656)     (656)  
Ending balance (in shares) at Dec. 31, 2023   12,880      
Ending balance at Dec. 31, 2023 27,307 $ 1 135,490 (106,992) (1,192)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 796   796    
Common stock issued under equity award plans (in shares)   113      
Shares canceled or surrendered as payment of tax withholding and other (in shares)   (38)      
Shares canceled or surrendered as payment of tax withholding and other (233)   (233)    
Repurchase of company stock (in shares)   292      
Repurchase of company stock $ (1,928)     (1,928)  
Common stock issued under employee stock purchase plan (in shares) 25 25      
Common stock issued under employee stock purchase plan $ 145   145    
Cash dividends (448)     (448)  
Currency translation adjustment (529)       (529)
Net income 1,659     1,659  
Ending balance (in shares) at Mar. 31, 2024   12,688      
Ending balance at Mar. 31, 2024 $ 26,769 $ 1 136,198 (107,709) (1,721)
Beginning balance (in shares) at Jun. 30, 2024 12,510 12,510      
Beginning balance at Jun. 30, 2024 $ 25,991 $ 1 136,644 (108,738) (1,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 917   917    
Common stock issued under equity award plans (in shares)   140      
Shares canceled or surrendered as payment of tax withholding and other (in shares)   (48)      
Shares canceled or surrendered as payment of tax withholding and other (347)   (347)    
Repurchase of company stock (in shares)   140      
Repurchase of company stock (1,114)     (1,114)  
Common stock issued under employee stock purchase plan (in shares)   22      
Common stock issued under employee stock purchase plan 133   133    
Cash dividends (500)     (500)  
Currency translation adjustment 791       791
Net income 1,826     1,826  
Ending balance (in shares) at Sep. 30, 2024   12,484      
Ending balance at Sep. 30, 2024 $ 27,697 $ 1 137,347 (108,526) (1,125)
Beginning balance (in shares) at Jun. 30, 2024 12,510 12,510      
Beginning balance at Jun. 30, 2024 $ 25,991 $ 1 136,644 (108,738) (1,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued under employee stock purchase plan (in shares) 44        
Net income $ 7,846        
Ending balance (in shares) at Mar. 31, 2025 12,581 12,581      
Ending balance at Mar. 31, 2025 $ 34,011 $ 1 139,068 (103,511) (1,547)
Beginning balance (in shares) at Sep. 30, 2024   12,484      
Beginning balance at Sep. 30, 2024 27,697 $ 1 137,347 (108,526) (1,125)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 1,722   1,722    
Common stock issued under equity award plans (in shares)   133      
Shares canceled or surrendered as payment of tax withholding and other (in shares)   (67)      
Shares canceled or surrendered as payment of tax withholding and other (898)   (898)    
Cash dividends (502)     (502)  
Currency translation adjustment (680)       (680)
Net income 2,550     2,550  
Ending balance (in shares) at Dec. 31, 2024   12,550      
Ending balance at Dec. 31, 2024 29,889 $ 1 138,171 (106,478) (1,805)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 1,521   1,521    
Common stock issued under equity award plans (in shares)   22      
Shares canceled or surrendered as payment of tax withholding and other (in shares)   (44)      
Shares canceled or surrendered as payment of tax withholding and other $ (771)   (771)    
Common stock issued under employee stock purchase plan (in shares) 22 53      
Common stock issued under employee stock purchase plan $ 147   147    
Cash dividends (503)     (503)  
Currency translation adjustment 258       258
Net income $ 3,470     3,470  
Ending balance (in shares) at Mar. 31, 2025 12,581 12,581      
Ending balance at Mar. 31, 2025 $ 34,011 $ 1 $ 139,068 $ (103,511) $ (1,547)